Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Hepatic gene replacement improves energy metabolism and survival in a mouse model of neonatal mitochondrial disease GRACILE syndrome

Banerjee, Rishi ; Purhonen, Janne ; Sultana, Nasrin ; Ros, Oliver ; Nieminen, Anni I. ; Kietz, Christa ; Fellman, Vineta LU orcid and Kallijärvi, Jukka LU (2026) In Molecular Therapy 34(8). p.4518-4530
Abstract

Preclinical gene therapy studies of mitochondrial diseases remain limited due to the typically multi-organ manifestations and the scarcity of physiologically relevant animal models. Mutations in BCS1L , a nuclear gene encoding an assembly factor for mitochondrial complex III (CIII), are the most common cause of CIII deficiency. The most severe phenotype, GRACILE syndrome, is caused by a homozygous Finnish founder mutation ( c . A232G , p . S78G ). The corresponding Bcs1l p . S78G knockin mouse model recapitulates the human disease, with juvenile-onset hepatopathy, tubulopathy, growth restriction, segmental progeria, and short survival. Here, we performed liver-targeted recombinant adeno-associated virus (rAAV)-mediated gene... (More)

Preclinical gene therapy studies of mitochondrial diseases remain limited due to the typically multi-organ manifestations and the scarcity of physiologically relevant animal models. Mutations in BCS1L , a nuclear gene encoding an assembly factor for mitochondrial complex III (CIII), are the most common cause of CIII deficiency. The most severe phenotype, GRACILE syndrome, is caused by a homozygous Finnish founder mutation ( c . A232G , p . S78G ). The corresponding Bcs1l p . S78G knockin mouse model recapitulates the human disease, with juvenile-onset hepatopathy, tubulopathy, growth restriction, segmental progeria, and short survival. Here, we performed liver-targeted recombinant adeno-associated virus (rAAV)-mediated gene replacement in this model. A single intraperitoneal injection of rAAVs encoding wild-type Bcs1l restored CIII assembly and activity in the liver, preventing hepatopathy. Hepatocyte-specific correction was sufficient to alleviate hypoglycemia, improve growth, normalize systemic metabolism, and extend survival by nearly 2-fold, despite persistent CIII deficiency in other tissues. Remarkably, restoring CIII activity in the liver robustly corrected the skeletal muscle transcriptomic changes, particularly those linked to altered energy substrate utilization. These results underscore the central role of the liver in systemic energy homeostasis and growth regulation in multi-organ mitochondrial diseases and demonstrate the therapeutic potential of hepatocyte-directed gene replacement in phenotypes with prominent hepatopathy.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
BCS1L, energy metabolism, GRACILE syndrome, hepatopathy, mitochondrial disease, rAAV gene therapy, respiratory complex III deficiency, tissue crosstalk
in
Molecular Therapy
volume
34
issue
8
pages
13 pages
publisher
Nature Publishing Group
external identifiers
  • scopus:105038188066
  • pmid:42035262
ISSN
1525-0016
DOI
10.1016/j.ymthe.2026.04.044
language
English
LU publication?
yes
id
dfd49464-8a9c-4ace-bdaf-25fbed8cf348
date added to LUP
2026-08-28 10:24:26
date last changed
2026-08-29 03:00:02
@article{dfd49464-8a9c-4ace-bdaf-25fbed8cf348,
  abstract     = {{<p>Preclinical gene therapy studies of mitochondrial diseases remain limited due to the typically multi-organ manifestations and the scarcity of physiologically relevant animal models. Mutations in BCS1L , a nuclear gene encoding an assembly factor for mitochondrial complex III (CIII), are the most common cause of CIII deficiency. The most severe phenotype, GRACILE syndrome, is caused by a homozygous Finnish founder mutation ( c . A232G , p . S78G ). The corresponding Bcs1l <sup> p . S78G </sup> knockin mouse model recapitulates the human disease, with juvenile-onset hepatopathy, tubulopathy, growth restriction, segmental progeria, and short survival. Here, we performed liver-targeted recombinant adeno-associated virus (rAAV)-mediated gene replacement in this model. A single intraperitoneal injection of rAAVs encoding wild-type Bcs1l restored CIII assembly and activity in the liver, preventing hepatopathy. Hepatocyte-specific correction was sufficient to alleviate hypoglycemia, improve growth, normalize systemic metabolism, and extend survival by nearly 2-fold, despite persistent CIII deficiency in other tissues. Remarkably, restoring CIII activity in the liver robustly corrected the skeletal muscle transcriptomic changes, particularly those linked to altered energy substrate utilization. These results underscore the central role of the liver in systemic energy homeostasis and growth regulation in multi-organ mitochondrial diseases and demonstrate the therapeutic potential of hepatocyte-directed gene replacement in phenotypes with prominent hepatopathy.</p>}},
  author       = {{Banerjee, Rishi and Purhonen, Janne and Sultana, Nasrin and Ros, Oliver and Nieminen, Anni I. and Kietz, Christa and Fellman, Vineta and Kallijärvi, Jukka}},
  issn         = {{1525-0016}},
  keywords     = {{BCS1L; energy metabolism; GRACILE syndrome; hepatopathy; mitochondrial disease; rAAV gene therapy; respiratory complex III deficiency; tissue crosstalk}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{4518--4530}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Molecular Therapy}},
  title        = {{Hepatic gene replacement improves energy metabolism and survival in a mouse model of neonatal mitochondrial disease GRACILE syndrome}},
  url          = {{http://dx.doi.org/10.1016/j.ymthe.2026.04.044}},
  doi          = {{10.1016/j.ymthe.2026.04.044}},
  volume       = {{34}},
  year         = {{2026}},
}